Valacyclovir: Difference between revisions
Gerald Chi (talk | contribs) mNo edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Valacyclovir}} | |||
{{CMG}} | |||
==Overview== | |||
'''Valaciclovir''' ([[International Nonproprietary Name|INN]]) or '''valacyclovir''' ([[United States Adopted Name|USAN]]) is an [[antiviral drug]] used in the management of [[herpes simplex]], [[herpes zoster]] (shingles), and [[Herpes B virus|herpes B]]. It is a [[prodrug]], being converted {{lang|la|''[[in vivo]]''}} to [[aciclovir]]. It is marketed by [[GlaxoSmithKline]] under the trade names '''Valtrex''' and '''Zelitrex'''. Valaciclovir has been available as a generic drug in the U.S. since November 25, 2009.<ref>{{Cite news|last=Ahmed |first=Rumman |url=http://online.wsj.com/article/SB125931422280866181.html |title=Ranbaxy Launches Generic Valtrex in U.S. |work=[[The Wall Street Journal]] |date=2009-11-27 |accessdate=2010-01-16 }}</ref> | |||
==Category== | |||
Antiviral | |||
==US Brand Names== | |||
Valtrex<sup>®</sup> (Zelitrex) | |||
==FDA Package Insert== | |||
'''[[Valacyclovir description|Description]]''' | |||
'''| [[Valacyclovir clinical pharmacology|Clinical Pharmacology]]''' | |||
'''| [[Valacyclovir microbiology|Microbiology]]''' | |||
'''| [[Valacyclovir indications and usage|Indications and Usage]]''' | |||
'''| [[Valacyclovir contraindications|Contraindications]]''' | |||
'''| [[Valacyclovir warnings and precautions|Warnings and Precautions]]''' | |||
'''| [[Valacyclovir adverse reactions|Adverse Reactions]]''' | |||
'''| [[Valacyclovir overdosage|Overdosage]]''' | |||
'''| [[Valacyclovir clinical studies|Clinical Studies]]''' | |||
'''| [[Valacyclovir dosage and administration|Dosage and Administration]]''' | |||
'''| [[Valacyclovir compatibility reconstitution and stability|Compatibility, Reconstitution, and Stability]]''' | |||
'''| [[Valacyclovir directions for use|Directions For Use]]''' | |||
'''| [[Valacyclovir how supplied|How Supplied]]''' | |||
'''| [[Valacyclovir labels and packages|Labels and Packages]]''' | |||
==Mechanism of Action== | |||
==References== | |||
{{Reflist|2}} | |||
[[Category:Antibiotics]] | |||
[[Category:Wikinfect]] | |||
Revision as of 19:39, 30 December 2013
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Valaciclovir (INN) or valacyclovir (USAN) is an antiviral drug used in the management of herpes simplex, herpes zoster (shingles), and herpes B. It is a prodrug, being converted [in vivo] error: {{lang}}: text has italic markup (help) to aciclovir. It is marketed by GlaxoSmithKline under the trade names Valtrex and Zelitrex. Valaciclovir has been available as a generic drug in the U.S. since November 25, 2009.[1]
Category
Antiviral
US Brand Names
Valtrex® (Zelitrex)
FDA Package Insert
Description | Clinical Pharmacology | Microbiology | Indications and Usage | Contraindications | Warnings and Precautions | Adverse Reactions | Overdosage | Clinical Studies | Dosage and Administration | Compatibility, Reconstitution, and Stability | Directions For Use | How Supplied | Labels and Packages
Mechanism of Action
References
- ↑ Ahmed, Rumman (2009-11-27). "Ranbaxy Launches Generic Valtrex in U.S." The Wall Street Journal. Retrieved 2010-01-16.